Bdaxit 1mg Tablet

Gain a clear understanding of Bdaxit 1mg Tablet, a product by BDR Pharmaceuticals Internationals Pvt formulated with the salt combination Axitinib (1mg). This medication is commonly used for Kidney cancer. Continue reading to explore comprehensive details about its application and other essential information to help you make informed decisions regarding your health needs.

MRP: ₹ 450
Packing: 14.0 tablets in 1 strip
Salt Combination: Axitinib (1mg)
Brand: BDR Pharmaceuticals Internationals Pvt
Uses: Kidney cancer

Description

Bdaxit 1mg Tablet is an anti-cancer medicine used in the treatment of kidney cancer
Bdaxit 1mg Tablet can be taken with or without food, but try to have it at the same time every day to get the most benefits
Your doctor will decide what dose is necessary and how often you need to take it
This will depend on what you are being treated for and may change from time to time
You should take it exactly as your doctor has advised
Taking it in the wrong way or taking too much can cause very serious side effects
It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
The most common side effects of this medicine include high blood pressure, joint pain, and loss of appetite
Diarrhea, shortness of breath, can be serious sometimes so take medicine to treat it as prescribed by the doctor or stay hydrated
Your doctor may advise for regular blood pressure checkups while you are taking this medicine
Inform your doctor if you notice a severe headache, confusion, problems with your eyesight, nausea or vomiting.
Before taking it, tell your doctor if you have thyroid problems, liver or bleeding problems or are taking any medicines to treat infections
Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using
This medicine is not recommended during pregnancy or while breastfeeding
The use of effective contraception by females during treatment is important to avoid pregnancy.

Cautions

Liver:	CAUTION: Bdaxit 1mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Bdaxit 1mg Tablet may be needed. Please consult your doctor. Limited information is available on the use of Bdaxit 1mg Tablet in patients with the severe liver disease.
Kidney:	SAFE IF PRESCRIBED: Bdaxit 1mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Bdaxit 1mg Tablet is recommended.
Driving:	UNSAFE: Bdaxit 1mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Breast feeding:	CONSULT YOUR DOCTOR: Bdaxit 1mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnency:	CONSULT YOUR DOCTOR: Bdaxit 1mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Alcohol:	CONSULT YOUR DOCTOR: It is not known whether it is safe to consume alcohol with Bdaxit 1mg Tablet. Please consult your doctor.
Drug Action:	Tyrosine kinase inhibitors
Therapeutic class:	ANTI NEOPLASTICS
Habit Forming:	No
Chemical Class:	Enzamide and Indazole Derivative